openPR Logo
Press release

Download Sample Global Virus Like Particles Market and Clinical Trial Insight 2023

10-25-2017 06:27 AM CET | Health & Medicine

Press release from: KuicK Research

Download Sample Global Virus Like Particles Market and Clinical

“Global Virus Like Particles Market and Clinical Trial Insight 2023” report highlights:

Advances in Virus like Particles as a Vaccination
Production Process of Virus like Particle based Vaccines
Market Analysis of Virus like Particles Vaccines
Global Virus Like Particle Vaccines Clinical Pipeline Insight: 60 Vaccines
Marketed Virus Like Particle Vaccines Clinical Insight: 5 Vaccines
Future Perspective of Virus like Particles Vaccines

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-global-virus-like-particles-market-and-clinical-trial-insight-2023.php

Table of Contents

1. Virus like Particles andndash; New Generation of Vaccines
1.1 Introduction
1.2 Requirements for Virus like Particles Assembly

2. Virus Candidates for Development of Virus like Particle Vaccines
2.1 Animal Virus-like Particles as Vaccine Immunogens
2.2 Plant Virus based Virus like Particles

3. Current Advances in Virus like Particles as a Vaccination Approach against Infectious Diseases
3.1 HIV-1 Virus like Particles
3.2 Hepatitis C Virus
3.3 Malaria
3.4 Newcastle Disease
3.5 Filoviruses
3.6 Norovirus

4. Production Process of Virus like Particle based Vaccines
4.1 Expression Systems
4.2 Downstream Processing of Virus like Particle Based Vaccines

5. Market Analysis of Virus like Particles Vaccines
5.1 Introduction
5.2 Market of Virus like Particle Vaccines

6. Global Virus Like Particle Vaccines Clinical Pipeline Overview

7. Global Virus like Particle Vaccines Market Dynamics
7.1 Favorable Parameters
7.2 Commercialization Challenges

8. Future Perspective of Virus like Particles Vaccines

9. Global Virus Like Particle Vaccines Clinical Pipeline by Company, Indication and Phase
9.1 Research
9.2 Preclinical
9.3 Phase-I
9.4 Phase-I/II
9.5 Phase-II
9.6 Phase-II/III
9.7 Phase-III

10. Marketed Virus Like Particle Vaccines Clinical Insight
10.1 Human papillomavirus vaccine recombinant quadrivalent (Gardasil and Silgard)
10.2 Human papillomavirus vaccine recombinant bivalent (Cervarix)
10.3 Human Papillomavirus Vaccine Recombinant Nonavalent (GARDASIL9)
10.4 Influenza Virus Vaccine Trivalent (CadiFlu-S)
10.5 Influenza A Virus H1N1 Vaccine (CadiFlu)

11. Competitive Landscape
11.1 Agilvax
11.2 Allergy Therapeutics
11.3 ANGANY Genetics
11.4 CPL Biologicals
11.5 Cytos Biotechnology
11.6 GeoVax Labs
11.7 GlaxoSmithKline
11.8 Medicago
11.9 MedImmune
11.10 Merck
11.11 Novavax
11.12 Serum Institute of India
11.13 Takeda
11.14 TechnoVax
11.15 Xiamen Innovax Biotech

Figure 1-1: Non-Enveloped Virus like Particle Production through Pathogen Component and Fusion to a Vaccine Target Antigen
Figure 1-2: Diagram of Enveloped Virus like Particle Production
Figure 1-3: Requirements for the Assembly of Virus like Particles
Figure 2-1: Types of Plant Virus for Virus like Particles Development
Figure 3-1: Modification of HIV-1 Envelope Trimers for Virus like Particle Vaccine
Figure 3-2: Virus like Particle Vaccine Strategy against Hepatitis C virus
Figure 3-3: New Castle Virus for Virus like Particle Vaccine Development
Figure 3-4: Production of Ebola Virus like Particles from Plasmids
Figure 4-1: Downstream Process Strategy for Virus like Particle Purification
Figure 5-1: Global - Market Growth Potential of Vaccine Industry (US$, Billion), 2017-2023
Figure 6-1: Global andndash; Virus Like Particle Vaccines Pipeline by Phase (%), 2017 till 2023
Figure 6 2: Global andndash;Virus Like Particle Vaccines Pipeline by Phase (Number), 2017 till 2023
Figure 6-3: Global andndash; Virus Like Particle Vaccines Pipeline by Phase (%),2017 till 2023
Figure 6-4: Global andndash; Virus Like Particle Vaccines Pipeline by Phase (Number), 2017 till 2023
Figure 7-1: Favorable Market Parameters for Vaccine Development
Figure 7-2: Challenges to the Market Growth of Vaccines
Figure 8-1: Future Scientific Innovations and Challenges for Vaccine Development

Table 3-1: Development Status of Virus like Particle Vaccine Candidates
Table 4-1: Properties of Various Expression Systems for Production of Virus like Particle

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Download Sample Global Virus Like Particles Market and Clinical Trial Insight 2023 here

News-ID: 784242 • Views: 168

More Releases from KuicK Research

Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
US Breast Cancer Drug Market, Price, Dosage and Clinical Pipeline Insight 2025
"US Breast Cancer Drug Market, Price, Dosage and Clinical Pipeline Insight 2025" Report Highlights: US Breast Cancer Drug Market Opportunity: US$ 20 Billion US Breast Cancer Drug Clinical Pipeline by Company, Phase, Drug Class and Patient Segment US Breast Cancer Marketed Drugs: 42 Drugs US Breast Cancer Drug Clinical Pipeline: 317 Drugs Dosage and Pricing Insight for Preventive and Treatment Drugs US Breast Cancer Drug Market Dynamics For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Download Report:
Download Global Cell Therapy Market, Clinical Trials, Therapy Price and Opportun …
"Global Cell Therapy Market, Clinical Trials, Therapy Price and Opportunity Insight 2026" Report Highlights: Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 Cell Therapy Clinical Trial Insight by Indication, Company and Country Global Cell Therapy Clinical Pipeline: 767 Cell Therapies Globally Marketed Cell Therapies: 25 Cell Therapies Maximum Number of Marketed Cell Therapies In USA: 15 Therapies Price and Product Insight By Region/Country Regional Analysis of the Cell Therapy Market

All 5 Releases


More Releases for Virus

Virus Clearance Market 2024 - Analysis and Trends
Virus elimination and inactivation continue to emerge as an important factor in overall bioprocess safety. As bioprocesses, products, and unit operations flourish, viral clearance will become more customized to industrial and individual situations. At the same time, the global viral clearance market will keep extending its purview. Viral clearance is also called viral safety. For example, in case of inactivation of reagents such as monoclonal antibodies and recombinant proteins, companies,
Nanoscale Virus Trap Molecule Market
Advancement into scientific research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evolution, things are becoming miniature in size, be it electronic chips, medical devices, or pharmaceutical drug. However, miniaturization, also referred as nanotechnology, doesn’t compromise on the product quality and effectiveness. Instead there is improved quality and features delivered via this technology. Nanotechnology has a real potential to revolutionize
Global Oncolytic Virus Therapy Pipeline Analysis
Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which
Nanoscale Virus Trap Molecule Market
Advancement into scientific research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evolution, things are becoming miniature in size, be it electronic chips, medical devices, or pharmaceutical drug. However, miniaturization, also referred as nanotechnology, doesn’t compromise on the product quality and effectiveness. Instead there is improved quality and features delivered via this technology. Nanotechnology has a real potential to revolutionize
Virus Clearance Market : Global Markets & Advanced Technologies
Viral clearance can be performed by numerous methods depending on product type, technique for production, and whether it is a medical device or not. Examples of the techniques used in viral clearance are qRT-PCR, PCR, real time PCR, ELISA (EIA), western blot, and transmission EM. Viral clearance is vital for final confirmation about the acceptable level of safety which can be taken in for a final product. The success ratio